Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delapril versus lisinopril and placebo in essential hypertension
2006-001823-20Phase 4Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of delapril and lisinopril in essential hypertension (4 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoints: Mean change from baseline to final visit in sitting diastolic blood pressure and Non-inferiority of delapril 30 mg twice daily versus lisinopril 20 mg once daily. Started Mar 2007; status: completed.
02
Drugs
delaprillisinopril
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2006-001823-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001823-20.